0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Device Viral Inactivation Testing Market Research Report 2026
Published Date: 2026-01-29
|
Report Code: QYRE-Auto-15D18515
Home | Market Reports | Health| Medical Facilities & Services
Global Medical Device Viral Inactivation Testing Market Research Report 2024
BUY CHAPTERS

Global Medical Device Viral Inactivation Testing Market Research Report 2026

Code: QYRE-Auto-15D18515
Report
2026-01-29
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Device Viral Inactivation Testing Market Size

The global Medical Device Viral Inactivation Testing market was valued at US$ 200 million in 2025 and is anticipated to reach US$ 532 million by 2032, at a CAGR of 15.0% from 2026 to 2032.

Medical Device Viral Inactivation Testing Market

Medical Device Viral Inactivation Testing Market

Medical Device Viral Inactivation Testing is a service project specifically designed for medical devices that come into contact with biological fluids or tissues. This testing ensures that the device effectively eliminates or inactivates viruses, thereby preventing the transmission of infections during medical procedures. The test involves subjecting the device to a controlled environment with a known virus concentration and assessing its ability to reduce the viral load to an acceptable level. The significance of Medical Device Viral Inactivation Testing lies in its role in maintaining patient safety and preventing healthcare-associated infections. The functional benefits of this testing include the validation of the device's effectiveness in inactivating viruses, which is crucial for devices intended for reuse or those that come into direct contact with patients. By confirming the device's viral inactivation capabilities, this testing service contributes to the overall quality and reliability of medical devices.
In the future, the development trends of the Medical Device Viral Inactivation Testing industry will primarily manifest in the innovation of testing technologies and methods, updates to testing standards, the development of personalized testing solutions, the enhancement of automation and intelligence in testing processes, the advancement of internationalization and standardization, improvements in cost-effectiveness, changes in market demand, and shifts in the regulatory environment. With advancements in science and technology, new testing technologies and methods will be developed to enhance the accuracy and efficiency of viral inactivation testing, adapting to the characteristics of different medical devices and viruses. Automated and intelligent testing processes will utilize advanced automated equipment and analytical software to improve accuracy and efficiency while reducing human errors. The advancement of internationalization and standardization will ensure global recognition of testing results, while improvements in cost-effectiveness will make viral inactivation testing more economically viable. As medical technology progresses and new medical devices emerge, the demand for viral inactivation testing may change, requiring testing institutions to adapt to new market needs. Regulatory agencies may impose higher requirements for the viral inactivation performance of medical devices, necessitating testing institutions to adapt to these changes to ensure compliance of their services. These comprehensive trends will collectively drive the development of the Medical Device Viral Inactivation Testing industry, providing more accurate, efficient, and reliable services to the medical device industry.
This report delivers a comprehensive overview of the global Medical Device Viral Inactivation Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Device Viral Inactivation Testing. The Medical Device Viral Inactivation Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Device Viral Inactivation Testing market comprehensively. Regional market sizes by Type, by Application, by Biological Characteristics & Structure of Viruse, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Device Viral Inactivation Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Medical Device Viral Inactivation Testing Market Report

Report Metric Details
Report Name Medical Device Viral Inactivation Testing Market
Accounted market size in 2025 US$ 200 million
Forecasted market size in 2032 US$ 532 million
CAGR 15.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • DNA-based
  • RNA-based
Segment by Biological Characteristics & Structure of Viruse
  • Enveloped Viruses
  • Non-enveloped Viruses
Segment by Testing Method
  • Biocompatibility Testing
  • Microbiological & Reusability Validation
  • Chemical Composition Analysis
Segment by Application
  • Active Implant Medical Devices
  • Active Medical Equipment
  • In Vitro Diagnostic Equipment
  • Ophthalmic Medical Equipment
  • Vascular Medical Equipment
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo, SGS, Pacific BioLabs, Creative Biogene, ProPharma Group, Cormica Lab (Wickham Micro), CTI, WuXi AppTec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Biological Characteristics & Structure of Viruse, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Medical Device Viral Inactivation Testing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Medical Device Viral Inactivation Testing Market growing?

Ans: The Medical Device Viral Inactivation Testing Market witnessing a CAGR of 15.0% during the forecast period 2026-2032.

What is the Medical Device Viral Inactivation Testing Market size in 2032?

Ans: The Medical Device Viral Inactivation Testing Market size in 2032 will be US$ 532 million.

Who are the main players in the Medical Device Viral Inactivation Testing Market report?

Ans: The main players in the Medical Device Viral Inactivation Testing Market are Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo, SGS, Pacific BioLabs, Creative Biogene, ProPharma Group, Cormica Lab (Wickham Micro), CTI, WuXi AppTec

What are the Application segmentation covered in the Medical Device Viral Inactivation Testing Market report?

Ans: The Applications covered in the Medical Device Viral Inactivation Testing Market report are Active Implant Medical Devices, Active Medical Equipment, In Vitro Diagnostic Equipment, Ophthalmic Medical Equipment, Vascular Medical Equipment, Other

What are the Type segmentation covered in the Medical Device Viral Inactivation Testing Market report?

Ans: The Types covered in the Medical Device Viral Inactivation Testing Market report are DNA-based, RNA-based

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 DNA-based
1.2.3 RNA-based
1.3 Market by Biological Characteristics & Structure of Viruse
1.3.1 Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Biological Characteristics & Structure of Viruse: 2021 vs 2025 vs 2032
1.3.2 Enveloped Viruses
1.3.3 Non-enveloped Viruses
1.4 Market by Testing Method
1.4.1 Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Testing Method: 2021 vs 2025 vs 2032
1.4.2 Biocompatibility Testing
1.4.3 Microbiological & Reusability Validation
1.4.4 Chemical Composition Analysis
1.5 Market by Application
1.5.1 Global Medical Device Viral Inactivation Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Active Implant Medical Devices
1.5.3 Active Medical Equipment
1.5.4 In Vitro Diagnostic Equipment
1.5.5 Ophthalmic Medical Equipment
1.5.6 Vascular Medical Equipment
1.5.7 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Medical Device Viral Inactivation Testing Market Perspective (2021–2032)
2.2 Global Medical Device Viral Inactivation Testing Growth Trends by Region
2.2.1 Global Medical Device Viral Inactivation Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Medical Device Viral Inactivation Testing Historic Market Size by Region (2021–2026)
2.2.3 Medical Device Viral Inactivation Testing Forecasted Market Size by Region (2027–2032)
2.3 Medical Device Viral Inactivation Testing Market Dynamics
2.3.1 Medical Device Viral Inactivation Testing Industry Trends
2.3.2 Medical Device Viral Inactivation Testing Market Drivers
2.3.3 Medical Device Viral Inactivation Testing Market Challenges
2.3.4 Medical Device Viral Inactivation Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Device Viral Inactivation Testing Players by Revenue
3.1.1 Global Top Medical Device Viral Inactivation Testing Players by Revenue (2021–2026)
3.1.2 Global Medical Device Viral Inactivation Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Medical Device Viral Inactivation Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Medical Device Viral Inactivation Testing Revenue
3.4 Global Medical Device Viral Inactivation Testing Market Concentration Ratio
3.4.1 Global Medical Device Viral Inactivation Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Device Viral Inactivation Testing Revenue in 2025
3.5 Global Key Players of Medical Device Viral Inactivation Testing Head Offices and Areas Served
3.6 Global Key Players of Medical Device Viral Inactivation Testing, Products and Applications
3.7 Global Key Players of Medical Device Viral Inactivation Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Medical Device Viral Inactivation Testing Breakdown Data by Type
4.1 Global Medical Device Viral Inactivation Testing Historic Market Size by Type (2021–2026)
4.2 Global Medical Device Viral Inactivation Testing Forecasted Market Size by Type (2027–2032)
5 Medical Device Viral Inactivation Testing Breakdown Data by Application
5.1 Global Medical Device Viral Inactivation Testing Historic Market Size by Application (2021–2026)
5.2 Global Medical Device Viral Inactivation Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Medical Device Viral Inactivation Testing Market Size (2021–2032)
6.2 North America Medical Device Viral Inactivation Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Medical Device Viral Inactivation Testing Market Size by Country (2021–2026)
6.4 North America Medical Device Viral Inactivation Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Device Viral Inactivation Testing Market Size (2021–2032)
7.2 Europe Medical Device Viral Inactivation Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Medical Device Viral Inactivation Testing Market Size by Country (2021–2026)
7.4 Europe Medical Device Viral Inactivation Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Medical Device Viral Inactivation Testing Market Size (2021–2032)
8.2 Asia-Pacific Medical Device Viral Inactivation Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Medical Device Viral Inactivation Testing Market Size (2021–2032)
9.2 Latin America Medical Device Viral Inactivation Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Medical Device Viral Inactivation Testing Market Size by Country (2021–2026)
9.4 Latin America Medical Device Viral Inactivation Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Device Viral Inactivation Testing Market Size (2021–2032)
10.2 Middle East & Africa Medical Device Viral Inactivation Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Medical Device Viral Inactivation Testing Introduction
11.1.4 Charles River Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.1.5 Charles River Recent Development
11.2 Perfectus Biomed (NAMSA)
11.2.1 Perfectus Biomed (NAMSA) Company Details
11.2.2 Perfectus Biomed (NAMSA) Business Overview
11.2.3 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Introduction
11.2.4 Perfectus Biomed (NAMSA) Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.2.5 Perfectus Biomed (NAMSA) Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Medical Device Viral Inactivation Testing Introduction
11.3.4 Eurofins Scientific Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.3.5 Eurofins Scientific Recent Development
11.4 Nelson Labs
11.4.1 Nelson Labs Company Details
11.4.2 Nelson Labs Business Overview
11.4.3 Nelson Labs Medical Device Viral Inactivation Testing Introduction
11.4.4 Nelson Labs Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.4.5 Nelson Labs Recent Development
11.5 Texcell
11.5.1 Texcell Company Details
11.5.2 Texcell Business Overview
11.5.3 Texcell Medical Device Viral Inactivation Testing Introduction
11.5.4 Texcell Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.5.5 Texcell Recent Development
11.6 Intertek Group
11.6.1 Intertek Group Company Details
11.6.2 Intertek Group Business Overview
11.6.3 Intertek Group Medical Device Viral Inactivation Testing Introduction
11.6.4 Intertek Group Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.6.5 Intertek Group Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Medical Device Viral Inactivation Testing Introduction
11.7.4 LabCorp Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.7.5 LabCorp Recent Development
11.8 Syensqo
11.8.1 Syensqo Company Details
11.8.2 Syensqo Business Overview
11.8.3 Syensqo Medical Device Viral Inactivation Testing Introduction
11.8.4 Syensqo Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.8.5 Syensqo Recent Development
11.9 SGS
11.9.1 SGS Company Details
11.9.2 SGS Business Overview
11.9.3 SGS Medical Device Viral Inactivation Testing Introduction
11.9.4 SGS Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.9.5 SGS Recent Development
11.10 Pacific BioLabs
11.10.1 Pacific BioLabs Company Details
11.10.2 Pacific BioLabs Business Overview
11.10.3 Pacific BioLabs Medical Device Viral Inactivation Testing Introduction
11.10.4 Pacific BioLabs Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.10.5 Pacific BioLabs Recent Development
11.11 Creative Biogene
11.11.1 Creative Biogene Company Details
11.11.2 Creative Biogene Business Overview
11.11.3 Creative Biogene Medical Device Viral Inactivation Testing Introduction
11.11.4 Creative Biogene Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.11.5 Creative Biogene Recent Development
11.12 ProPharma Group
11.12.1 ProPharma Group Company Details
11.12.2 ProPharma Group Business Overview
11.12.3 ProPharma Group Medical Device Viral Inactivation Testing Introduction
11.12.4 ProPharma Group Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.12.5 ProPharma Group Recent Development
11.13 Cormica Lab (Wickham Micro)
11.13.1 Cormica Lab (Wickham Micro) Company Details
11.13.2 Cormica Lab (Wickham Micro) Business Overview
11.13.3 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Introduction
11.13.4 Cormica Lab (Wickham Micro) Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.13.5 Cormica Lab (Wickham Micro) Recent Development
11.14 CTI
11.14.1 CTI Company Details
11.14.2 CTI Business Overview
11.14.3 CTI Medical Device Viral Inactivation Testing Introduction
11.14.4 CTI Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.14.5 CTI Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Medical Device Viral Inactivation Testing Introduction
11.15.4 WuXi AppTec Revenue in Medical Device Viral Inactivation Testing Business (2021–2026)
11.15.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of DNA-based
 Table 3. Key Players of RNA-based
 Table 4. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Biological Characteristics & Structure of Viruse (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Enveloped Viruses
 Table 6. Key Players of Non-enveloped Viruses
 Table 7. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Testing Method (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Key Players of Biocompatibility Testing
 Table 9. Key Players of Microbiological & Reusability Validation
 Table 10. Key Players of Chemical Composition Analysis
 Table 11. Global Medical Device Viral Inactivation Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 12. Global Medical Device Viral Inactivation Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 13. Global Medical Device Viral Inactivation Testing Market Size by Region (US$ Million), 2021–2026
 Table 14. Global Medical Device Viral Inactivation Testing Market Share by Region (2021–2026)
 Table 15. Global Medical Device Viral Inactivation Testing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 16. Global Medical Device Viral Inactivation Testing Market Share by Region (2027–2032)
 Table 17. Medical Device Viral Inactivation Testing Market Trends
 Table 18. Medical Device Viral Inactivation Testing Market Drivers
 Table 19. Medical Device Viral Inactivation Testing Market Challenges
 Table 20. Medical Device Viral Inactivation Testing Market Restraints
 Table 21. Global Medical Device Viral Inactivation Testing Revenue by Players (US$ Million), 2021–2026
 Table 22. Global Medical Device Viral Inactivation Testing Market Share by Players (2021–2026)
 Table 23. Global Top Medical Device Viral Inactivation Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Medical Device Viral Inactivation Testing Revenue, 2025
 Table 24. Ranking of Global Top Medical Device Viral Inactivation Testing Companies by Revenue (US$ Million) in 2025
 Table 25. Global 5 Largest Players Market Share by Medical Device Viral Inactivation Testing Revenue (CR5 and HHI), 2021–2026
 Table 26. Global Key Players of Medical Device Viral Inactivation Testing, Headquarters and Area Served
 Table 27. Global Key Players of Medical Device Viral Inactivation Testing, Products and Applications
 Table 28. Global Key Players of Medical Device Viral Inactivation Testing, Date of General Availability (GA)
 Table 29. Mergers and Acquisitions, Expansion Plans
 Table 30. Global Medical Device Viral Inactivation Testing Market Size by Type (US$ Million), 2021–2026
 Table 31. Global Medical Device Viral Inactivation Testing Revenue Market Share by Type (2021–2026)
 Table 32. Global Medical Device Viral Inactivation Testing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 33. Global Medical Device Viral Inactivation Testing Revenue Market Share by Type (2027–2032)
 Table 34. Global Medical Device Viral Inactivation Testing Market Size by Application (US$ Million), 2021–2026
 Table 35. Global Medical Device Viral Inactivation Testing Revenue Market Share by Application (2021–2026)
 Table 36. Global Medical Device Viral Inactivation Testing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 37. Global Medical Device Viral Inactivation Testing Revenue Market Share by Application (2027–2032)
 Table 38. North America Medical Device Viral Inactivation Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 39. North America Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2021–2026
 Table 40. North America Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2027–2032
 Table 41. Europe Medical Device Viral Inactivation Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Europe Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2021–2026
 Table 43. Europe Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2027–2032
 Table 44. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Region (US$ Million), 2021–2026
 Table 46. Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Region (US$ Million), 2027–2032
 Table 47. Latin America Medical Device Viral Inactivation Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Latin America Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2021–2026
 Table 49. Latin America Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2027–2032
 Table 50. Middle East & Africa Medical Device Viral Inactivation Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2021–2026
 Table 52. Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (US$ Million), 2027–2032
 Table 53. Charles River Company Details
 Table 54. Charles River Business Overview
 Table 55. Charles River Medical Device Viral Inactivation Testing Product
 Table 56. Charles River Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 57. Charles River Recent Development
 Table 58. Perfectus Biomed (NAMSA) Company Details
 Table 59. Perfectus Biomed (NAMSA) Business Overview
 Table 60. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product
 Table 61. Perfectus Biomed (NAMSA) Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 62. Perfectus Biomed (NAMSA) Recent Development
 Table 63. Eurofins Scientific Company Details
 Table 64. Eurofins Scientific Business Overview
 Table 65. Eurofins Scientific Medical Device Viral Inactivation Testing Product
 Table 66. Eurofins Scientific Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 67. Eurofins Scientific Recent Development
 Table 68. Nelson Labs Company Details
 Table 69. Nelson Labs Business Overview
 Table 70. Nelson Labs Medical Device Viral Inactivation Testing Product
 Table 71. Nelson Labs Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 72. Nelson Labs Recent Development
 Table 73. Texcell Company Details
 Table 74. Texcell Business Overview
 Table 75. Texcell Medical Device Viral Inactivation Testing Product
 Table 76. Texcell Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 77. Texcell Recent Development
 Table 78. Intertek Group Company Details
 Table 79. Intertek Group Business Overview
 Table 80. Intertek Group Medical Device Viral Inactivation Testing Product
 Table 81. Intertek Group Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 82. Intertek Group Recent Development
 Table 83. LabCorp Company Details
 Table 84. LabCorp Business Overview
 Table 85. LabCorp Medical Device Viral Inactivation Testing Product
 Table 86. LabCorp Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 87. LabCorp Recent Development
 Table 88. Syensqo Company Details
 Table 89. Syensqo Business Overview
 Table 90. Syensqo Medical Device Viral Inactivation Testing Product
 Table 91. Syensqo Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 92. Syensqo Recent Development
 Table 93. SGS Company Details
 Table 94. SGS Business Overview
 Table 95. SGS Medical Device Viral Inactivation Testing Product
 Table 96. SGS Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 97. SGS Recent Development
 Table 98. Pacific BioLabs Company Details
 Table 99. Pacific BioLabs Business Overview
 Table 100. Pacific BioLabs Medical Device Viral Inactivation Testing Product
 Table 101. Pacific BioLabs Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 102. Pacific BioLabs Recent Development
 Table 103. Creative Biogene Company Details
 Table 104. Creative Biogene Business Overview
 Table 105. Creative Biogene Medical Device Viral Inactivation Testing Product
 Table 106. Creative Biogene Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 107. Creative Biogene Recent Development
 Table 108. ProPharma Group Company Details
 Table 109. ProPharma Group Business Overview
 Table 110. ProPharma Group Medical Device Viral Inactivation Testing Product
 Table 111. ProPharma Group Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 112. ProPharma Group Recent Development
 Table 113. Cormica Lab (Wickham Micro) Company Details
 Table 114. Cormica Lab (Wickham Micro) Business Overview
 Table 115. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product
 Table 116. Cormica Lab (Wickham Micro) Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 117. Cormica Lab (Wickham Micro) Recent Development
 Table 118. CTI Company Details
 Table 119. CTI Business Overview
 Table 120. CTI Medical Device Viral Inactivation Testing Product
 Table 121. CTI Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 122. CTI Recent Development
 Table 123. WuXi AppTec Company Details
 Table 124. WuXi AppTec Business Overview
 Table 125. WuXi AppTec Medical Device Viral Inactivation Testing Product
 Table 126. WuXi AppTec Revenue in Medical Device Viral Inactivation Testing Business (US$ Million), 2021–2026
 Table 127. WuXi AppTec Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Medical Device Viral Inactivation Testing Picture
 Figure 2. Global Medical Device Viral Inactivation Testing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Medical Device Viral Inactivation Testing Market Share by Type: 2025 vs 2032
 Figure 4. DNA-based Features
 Figure 5. RNA-based Features
 Figure 6. Global Medical Device Viral Inactivation Testing Market Size Comparison by Biological Characteristics & Structure of Viruse (US$ Million), 2021–2032
 Figure 7. Enveloped Viruses Features
 Figure 8. Non-enveloped Viruses Features
 Figure 9. Global Medical Device Viral Inactivation Testing Market Size Comparison by Testing Method (US$ Million), 2021–2032
 Figure 10. Biocompatibility Testing Features
 Figure 11. Microbiological & Reusability Validation Features
 Figure 12. Chemical Composition Analysis Features
 Figure 13. Global Medical Device Viral Inactivation Testing Market Size by Application (US$ Million), 2021–2032
 Figure 14. Global Medical Device Viral Inactivation Testing Market Share by Application: 2025 vs 2032
 Figure 15. Active Implant Medical Devices Case Studies
 Figure 16. Active Medical Equipment Case Studies
 Figure 17. In Vitro Diagnostic Equipment Case Studies
 Figure 18. Ophthalmic Medical Equipment Case Studies
 Figure 19. Vascular Medical Equipment Case Studies
 Figure 20. Other Case Studies
 Figure 21. Medical Device Viral Inactivation Testing Report Years Considered
 Figure 22. Global Medical Device Viral Inactivation Testing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 23. Global Medical Device Viral Inactivation Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 24. Global Medical Device Viral Inactivation Testing Market Share by Region: 2025 vs 2032
 Figure 25. Global Medical Device Viral Inactivation Testing Market Share by Players in 2025
 Figure 26. Global Medical Device Viral Inactivation Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 27. The Top 10 and 5 Players Market Share by Medical Device Viral Inactivation Testing Revenue in 2025
 Figure 28. North America Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. North America Medical Device Viral Inactivation Testing Market Share by Country (2021–2032)
 Figure 30. United States Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Canada Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Europe Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Europe Medical Device Viral Inactivation Testing Market Share by Country (2021–2032)
 Figure 34. Germany Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. France Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. U.K. Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Italy Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Russia Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Ireland Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Asia-Pacific Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Asia-Pacific Medical Device Viral Inactivation Testing Market Share by Region (2021–2032)
 Figure 42. China Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Japan Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. South Korea Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Southeast Asia Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. India Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Australia & New Zealand Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Latin America Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Latin America Medical Device Viral Inactivation Testing Market Share by Country (2021–2032)
 Figure 50. Mexico Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Brazil Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Middle East & Africa Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country (2021–2032)
 Figure 54. Israel Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. UAE Medical Device Viral Inactivation Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 57. Charles River Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 58. Perfectus Biomed (NAMSA) Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 59. Eurofins Scientific Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 60. Nelson Labs Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 61. Texcell Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 62. Intertek Group Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 63. LabCorp Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 64. Syensqo Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 65. SGS Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 66. Pacific BioLabs Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 67. Creative Biogene Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 68. ProPharma Group Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 69. Cormica Lab (Wickham Micro) Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 70. CTI Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 71. WuXi AppTec Revenue Growth Rate in Medical Device Viral Inactivation Testing Business (2021–2026)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS